Efficacy of Ureklin Kallidinogenase for Injection in the Treatment of Cerebral Infarction and Its Influence on Collateral Circulation Score, CXCL16 and CD40L

CHEN Wu

doi:10.14033/j.cnki.cfmr.2022.01.008

Home>Articles>Efficacy of Ureklin Kallidinogenase for Injection in the Treatment of Cerebral Infarction and Its Influence on Collateral Circulation Score, CXCL16 and CD40L

DOI: 10.14033/j.cnki.cfmr.2022.01.008

Efficacy of Ureklin Kallidinogenase for Injection in the Treatment of Cerebral Infarction and Its Influence on Collateral Circulation Score, CXCL16 and CD40L

CHEN Wu

Machine-generated Keywords：

Publication Date：2022-01-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 27-30 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(1)